La cadena de opciones muestra datos clave de las opciones de acciones de AvidXchange Holdings a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para AvidXchange Holdings..

AvidXchange Holdings (NASDAQ:AVDX) Bolsa, Cadena de Opciones

AvidXchange Holdings

AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.

AvidXchange Holdings, Inc. - Common Stock

AvidXchange Holdings Inc

ACV Auctions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACVA#NASDAQ">ACVA</a>) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 9.09 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $171.33 million which beat the analyst consensus estimate of $160.42 million by 6.80 percent. This is a 43.96 percent increase over sales of $119.01 million the same period last year.

Earnings

Earnings Beats

News

ACVA

ACV Auctions Q3 EPS $(0.10) Beats $(0.11) Estimate, Sales $171.33M Beat $160.42M Estimate

Retail Sales

PRCH

Porch Group Announced That It Lowered Its FY24 Sales Guidance From $450M-470M to $440M-455M

Guidance

SGHT

Sight Sciences Sees FY24 Revenue $81M-$83M Vs $82.16M Estimate

Eventbrite (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EB#NYSE">EB</a>) raises FY2024 sales outlook from $318.00 million-325.00 million to $322.00 million-326.00 million.

Eventbrite Raises FY2024 Sales Guidance from $318.00M-325.00M to $322.00M-326.00M  VS Est.322.03M

Stock Split

ANET

Arista Approved Four-For-One Forward Stock Split

WIIM

RIGL

Rigel Pharmaceuticals shares are trading higher after the company reported better-than-expected Q3 financial results.

CarGurus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARG#NASDAQ">CARG</a>) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.42 by 7.14 percent. The company reported quarterly sales of $231.358 million which beat the analyst consensus estimate of $223.537 million by 3.50 percent. This is a 5.44 percent increase over sales of $219.419 million the same period last year.

CARG

CarGurus Q3 2024 Adj. EPS $0.45 Beats $0.42 Estimate, Sales $231.358M Beat $223.537M Estimate

ADMA Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) FY 2024 and 2025 Total Revenue Guidance Increased to More Than $415 Million and $465 Million, Respectively.

ADMA

ADMA Biologics FY 2024 and 2025 Total Revenue Guidance Increased to More Than $415 Million and $465 Million, Respectively

BSLK

Bolt Projects Holdings Q3 EPS $0.32

UPLD

Upland Software shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

Golden Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDEN#NASDAQ">GDEN</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.10 by 80 percent. This is a 200 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $161.23 million which missed the analyst consensus estimate of $162.25 million by 0.63 percent. This is a 37.44 percent decrease over sales of $257.73 million the same period last year.

Earnings Misses

GDEN

Golden Entertainment Q3 EPS $0.18 Beats $0.10 Estimate, Sales $161.23M Miss $162.25M Estimate

aTyr Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATYR#NASDAQ">ATYR</a>) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.22) by 4.55 percent.

ATYR

aTyr Pharma Q3 2024 GAAP EPS $(0.23) Misses $(0.22) Estimate

Spyre Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRE#NASDAQ">SYRE</a>) reported quarterly losses of $(1.36) per share which missed the analyst consensus estimate of $(0.83) by 63.86 percent. This is a 85.44 percent increase over losses of $(9.34) per share from the same period last year.

SYRE

Spyre Therapeutics Q3 EPS $(1.36) Misses $(0.83) Estimate

Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) raises FY2024 Adj EPS guidance from $0.08-0.12 to $0.12-0.14 vs $0.10 analyst estimate. Narrows FY2024 sales outlook from $835.00 million-845.00 million to $837.00 million-843.00 million vs $841.44 million estimate.

MYGN

Myriad Genetics Raises FY2024 Adj EPS Guidance from $0.08-0.12 to $0.12-0.14 vs $0.10 Est; Narrows FY2024 Sales Guidance from $835.00M-845.00M to $837.00M-843.00M vs $841.44M Est

LCUT

Lifetime Brands shares are trading lower after the company reported worse-than-expected Q3 financial results and lowered its FY24 guidance and Q4 EPS guidance.

SLDP

Solid Power Continues To Expect 2024 Revenue Of $16M - $20M, Est $19.783M

HeartBeam (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAT#NASDAQ">BEAT</a>) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.17) by 11.76 percent.

BEAT

HeartBeam Q3 2024 GAAP EPS $(0.19) Misses $(0.17) Estimate

US Global Investors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GROW#NASDAQ">GROW</a>) reported quarterly earnings of $0.02 per share. This is a 300 percent increase over losses of $(0.01) per share from the same period last year. The company reported $2.16 million in sales this quarter. This is a 31.15 percent decrease over sales of $3.13 million the same period last year.

GROW

US Global Investors Q1 EPS $0.02 Up From $(0.01) YoY, Sales $2.16M Down From $3.13M YoY

Innovex International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INVX#NYSE">INVX</a>) reported quarterly earnings of $0.25 per share which met the analyst consensus estimate. This is a 47.92 percent decrease over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $151.82 million which beat the analyst consensus estimate of $135.00 million by 12.46 percent. This is a 9.15 percent increase over sales of $139.09 million the same period last year.

INVX

Innovex International Q3 Adj $0.25, Inline, Sales $151.82M Beat $135.00M Estimate

Eventbrite (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EB#NYSE">EB</a>) sees Q4 sales of $74.000 million-77.000 million vs $75.47 million estimate.

Eventbrite Sees Q4 Sales $74.000M-77.000M vs $75.47M Est

Narrows FY24 revenue view to $437M-$439M from $436M-$439M, consensus $437.22M. Published first on TheFly – the ultimate source for real-time, marke...

AvidXchange sees FY24 adjusted EPS 24c-25c, consensus 25c

AvidXchange Non-GAAP EPS of $0.07 in-line, revenue of $112.8M beats by $1.98M

AvidXchange Holdings, Inc. (AVDX) Q3 2024 Earnings Call Transcript

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Trump Media (DJT) jumps after Donald T...

Trump Media, broader market surge after Trump wins election: Morning Buzz

Avidxchange Holdings, Inc. ( ($AVDX) ) has released its Q3 earnings. Here is a breakdown of the information Avidxchange Holdings, Inc. presented to...

AvidXchange Reports Strong Q3 2024 Financial Performance

In a report released today, Ramsey El Assal from Barclays maintained a Buy rating on AvidXchange Holdings (AVDX – Research Report), with a price ta...

Barclays Sticks to Their Buy Rating for AvidXchange Holdings (AVDX)

KeyBanc analyst Alex Markgraff maintained a Buy rating on AvidXchange Holdings (AVDX – Research Report) today. The company's shares closed yesterda...

KeyBanc Sticks to Their Buy Rating for AvidXchange Holdings (AVDX)

Piper Sandler analyst Brent Bracelin raised the firm's price target on AvidXchange (AVDX) to $10 from $9 and keeps a Neutral rating on the shares. ...

AvidXchange price target raised to $10 from $9 at Piper Sandler

As previously reported, Compass Point analyst Dominick Gabriele upgraded AvidXchange (AVDX) to Buy from Neutral with a price target of $15, up from...

AvidXchange upgraded to Buy at Compass Point on 'Street high' FY26 view

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

JPMorgan, Five Below downgraded: Wall Street's top analyst calls

AAPL

ALGM

AVDX

CBOE

CELH

CROX

CTKB

DLTR

EXAS

FIVE

HNDAF

HNHAF

HNHPF

HUBS

IRBT

NTDOF

NTDOY

PACS

PLNT

RVLV

SMCI

SNOW

SRPT

STLA

TEVA

TNGX

TRMB

VANI

ZYME

Press Releases

AvidXchange and Workamajig Announce Exclusive Strategic Partnership to Empower Media Companies to Manage Invoices Seamlessly

AVDX Investigation: Kessler Topaz Meltzer & Check, LLP Encourages AvidXchange Holdings, Inc. (NASDAQ: AVDX) Investors with Significant Losses to Contact the Firm

Legal

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AvidXchange Holdings, Inc. - AVDX

General

AvidXchange 2025 Trends Survey Reveals Finance Leaders' Top Priorities

AvidXchange Announces Timing of Its Third Quarter 2024 Financial Results Conference Call and Webcast

Free Career Event Returns to Charlotte, Bringing Hiring Experts and Resources to Job Seekers

Analyst Ratings

Automation Drives Higher Career Satisfaction for Accounts Payable Professionals, New Survey Reveals

Comments

AvidXchange Holdings

AvidXchange Holdings (AVDX) Opciones

AvidXchange Holdings (NASDAQ:AVDX) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL